Dung-Tsa Chen

19PUBLICATIONS
129CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples and disabilityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 26, 2026
Early Longitudinal Changes in Radiomic Tumor Heterogeneity Predict Progression-Free Survival in Advanced Non-Small Cell Lung Cancer.

|Sep 24, 2026
Targeting TGFBR1 with the Investigational Inhibitor TP-6379 Improves Hematopoiesis in Low-Risk MDS Ex Vivo.

|Jul 28, 2026
CT-Derived Radiomic Signature of MUC6 Expression Improves Guideline-Based Risk Stratification in Intraductal Papillary Mucinous Neoplasms.

|May 13, 2026
HER-2 Altered Early-Stage Non-Small Cell Lung Cancer Had Better Survival than Triple-Negative Disease.

|Dec 18, 2025
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma.

Margaret A Park, Evan W Davis, Solomon Alhassan

|Dec 10, 2025
Timing of Durvalumab Consolidation and Survival in Non-Small Cell Lung Cancer: A Population-Based Analysis.

Tawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray

Pageof 4

Frequent Collaborators

6 joint publications

Jennifer Permuth

5 joint publications

Jamie Teer

4 joint publications

Paul Stewart

4 joint publications

John M Koomen